机器人辅助根治性前列腺切除术后90天勃起充盈度量表预测2年性功能结局
该前瞻性研究纳入540例术前IIEF-5评分为22-25分、接受单术者机器人辅助根治性前列腺切除术的男性,其中299例完成2年随访。研究引入患者自报的勃起充盈度百分比(%fullness)作为IIEF-5的定性补充,并评估其90天时对24个月性功能(定义为足以性交的勃起)的预测价值。结果显示年龄、BMI、病理分期、神经保留状态和90天%fullness三分位均为24个月性功能的显著预测因素。
要点
- 90天%fullness三分位(0-24%、25-74%、75-100%)可预测RARP术后24个月性功能。
- 90天时61%(181/299)勃起不足以性交,联合IIEF-5与%fullness可将早期干预目标降至43%(77/181)。
- %fullness作为IIEF-5的定性补充,有助于识别最可能从早期二次干预中获益的患者。
核心结论
- 引入%fullness作为IIEF-5的定性补充,并可单独作为90天预测2年性功能恢复的指标。
- 该初步报告为假设生成性研究,%fullness有助于识别最可能从早期二次干预中获益的男性。
研究设计与样本
- 前瞻性数据收集自540例术前IIEF-5评分为22-25分、接受单术者机器人辅助根治性前列腺切除术的男性。
- 其中299例在所有时间点至2年有完整数据。
- 除标准评估工具(IIEF-5和足以性交的勃起[ESI])外,询问患者「与术前相比,您勃起所能达到的充盈度是多少?」(范围0-100%)。
- 主要结局为基于90天%fullness三分位(0-24%、25-74%、75-100%)预测24个月性功能(定义为ESI)。
主要发现
- 24个月性功能的显著预测因素包括年龄、体重指数、病理分期、神经保留状态和%fullness三分位。
- 术前IIEF-5评分22-25分的男性在RARP术后90天评估时,181/299(61%)勃起不足以性交。
- 若使用IIEF-5评分1-6分,142/181(78%)男性将被列为早期干预目标。
- 若使用0-24%充盈度,88/181(49%)男性将被列为目标。
- 若同时使用IIEF-5评分和%fullness,目标人群减少至77/181(43%)男性。
临床怎么用
- %fullness可作为IIEF-5的定性补充,用于RARP术后90天评估勃起功能。
- 联合IIEF-5评分与%fullness可更精准地识别需要早期二次干预的勃起功能不足患者。
局限性
- 该初步报告为假设生成性研究。
- 仅299例(共540例)有完整随访数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To introduce a patient-reported erection fullness scale (%fullness) after robot-assisted radical prostatectomy (RARP) as a qualitative adjunct to the five-item version of the International Index of Erectile Function (IIEF-5) and as a 90-day predictor of 2-year potency outcomes. PATIENTS AND METHODS: Prospective data were collected from 540 men with preoperative IIEF-5 scores of 22-25 who underwent RARP by a single surgeon, and of whom 299 had complete data at all time points up to 2 years. In addition to standard assessment tools (IIEF-5 and erections sufficient for intercourse [ESI]), the men were asked to 'indicate the fullness you are able to achieve in erections compared to before surgery?' (range: 0-100%). The primary outcome was prediction of potency (defined as ESI) at 24 months, based on 90-day %fullness tertile (0-24%, 25-74% and 75-100%). RESULTS: A total of 299 men with complete follow-up were included in the study. Significant predictors of 24-month potency included age, body mass index, pathological stage, nerve-sparing status and %fullness tertiles. When the men (preoperative IIEF-5 score 22-25) were assessed at 90 days after RARP, 181/299 (61%) had erections inadequate for intercourse. If IIEF-5 scores of 1-6 were used, 142/181 men (78%) would be targeted for early intervention. By contrast, if 0-24% fullness was used, 88/181 men (49%) would be targeted. If both the IIEF-5 score and %fullness were used, this would be reduced to 77/181 men (43%). CONCLUSIONS: We introduce %fullness as a qualitative adjunct to the IIEF-5 score, and separately as a 90-day predictor of 2-year potency recovery. This initial report is hypothesis-generating, such that the use of %fullness enables the identification of men who are most likely to benefit from early, secondary intervention.
引用
- Huynh LM, Osann K, Skarecky D, et al. Predictive modelling of 2-year potency outcomes using a novel 90-day erection fullness scale after robot-assisted radical prostatectomy. BJU Int. 2018. PMID: 29520949. doi:10.1111/bju.14190
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。